Event Partners
For more information on becoming an event/media partner, please contact Jon Liong at jon.liong@lycheegroup.com or Jialing Dai at dai.jialing@pharmadj.com.
-
Lychee Group
Since 2008, Lychee Group has created high-profile events aimed at bringing together senior executives from all sides of the global biopharma ecosystem. We have helped launch some of the most well-known global conferences in China’s life sciences industry, including the long-running CHINATRIALS Summit, China Healthcare Investment Conference (CHIC), and BioCentury’s China Healthare Summit. Our first 10 years focused on bringing global executives from MNC’s to China. Our next 10 years will also focus on bringing executives from China’s new wave of innovative biopharma companies to the US and EU, as the Biopharma industry marches towards a borderless future. Our team is based in Shanghai, New Jersey and Rotterdam.
-
PharmaDJ
Founded in 2014, PharmaDJ has expanded from a media outlet to a business intelligence platform including data-driven research, event organization and strategy consulting. Our areas of interest cover the entire drug life cycle, from early drug research, scientific translation to clinical development, commercial strategies, as well as market access strategies and public relations & communication strategies. Our editorial team are based in Shanghai, Guangzhou, Beijing, Suzhou, Nanjing and New Jersey.
Co-Organized By
-
BAYHELIX GROUP
BayHelix Group is a non-profit, invitation-only organization of business leaders of Chinese heritage that fosters the growth of the life sciences and healthcare industry around the Pacific Rim and beyond. Founded in 2001, BayHelix has grown to over 300 members throughout the U.S., Canada, and Greater China. The membership base covers virtually all of the world’s top pharmaceutical and biopharmaceutical companies, as well as leading services and investment firms. Over one third of the members are senior executives, over 80% have PhDs in the life sciences, and nearly half have MBAs from the leading business schools in U.S.
Supported By
-
Haomai Technology
Haomai Technology uses big data to track global biopharmaceutical information and uncover trends and opportunities. Its membership platform integrates automated data scanning, knowledge building, and value assessment, delivering expert-driven insights for R&D, investment, and business development to help members stay ahead in a competitive landscape.
-
Haoyue Capital
Founded in January 2014, HaoYue Capital is dedicated to connecting China’s Life Sciences and Healthcare companies with global capital markets.
Our research and deal-making capabilities span key healthcare verticals, including Biotech, Medtech, Healthcare Services, Digital Health, and Diagnostics & Precision Medicine. We are among China’s largest teams of senior investment bankers focused exclusively on healthcare and life sciences, with deep sector expertise, extensive market knowledge, and a strong understanding of emerging industry trends.
We provide proprietary research, regular industry updates, and timely market insights to support informed investment decisions. As of 2024, HaoYue Capital has successfully completed hundreds of transactions. Over the past decade, we have developed extensive expertise in private placements, M&A transactions, restructuring, and complex public company deals, maintaining comprehensive capabilities across healthcare and life sciences subsectors.
-
L.E.K. Consulting
We’re L.E.K. Consulting, a global strategy consultancy working with business leaders to seize competitive advantage and amplify growth. Our insights are catalysts that reshape the trajectory of our clients’ businesses, uncovering opportunities and empowering them to master their moments of truth. Since 1983, our worldwide practice — spanning the Americas, Europe, Middle East and Asia-Pacific — has guided leaders across all industries from global corporations to emerging entrepreneurial businesses and private equity investors. Looking for more? Visit www.lek.com.
In Collaboration With